Encephalopathy in children infected by vertically transmitted human immunodeficiency virus;Encefalopatía en niños con infección por virus de inmunodeficiencia humana de transmisión vertical

Revista de Neurologia

Volumn 42, Issue 12, 2006, Pages 743-753

  Czornyj, Liliana A ^a,b  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b NONE   (Argentina)

Author keywords

Encephalopathy; HIV; Infantile neuro AIDS; Vertical transmission

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; ENFUVIRTIDE; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

BRAIN DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG DOSE REGIMEN; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; INCIDENCE; INFECTION PREVENTION; MICROCEPHALY; PATHOPHYSIOLOGY; RECOMMENDED DRUG DOSE; REVIEW; TOXOPLASMOSIS; VIRUS TRANSMISSION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARGENTINA; CHILD; HISTORY; HUMAN IMMUNODEFICIENCY VIRUS 1; PATHOLOGY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; ARGENTINA; BRAIN DISEASES; CHILD; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; HISTORY, 20TH CENTURY; HIV SEROPOSITIVITY; HIV-1; HUMANS;

EID: 33750133226     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4212.2005106     Document Type: Review

References (57)

1. Dickson D, Mattiace L, Kure K, Hutchins K, Lyman W, Brosnan C. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 1991; 64: 135-56.
2. Czornyj L, Carniglia L, Procak-Psarós C, Redondo J, Rocatagliata G, Rodríguez S, et al. Neurologic involvement in 70 HIV+ infants and children. Pediatr Neurol 1992; 5: 406.
3. Lobato M, Caldwell M, Ng P, Oxtoby M. Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium. J Pediatr 1995; 126: 710-5.
4. Tellechea-Rotta N, Legido A. Síndrome de inmunodeficiencia adquirida por transmisión vertical: alteraciones neurológicas. Rev Neurol 2003; 36: 255-63.
5. Kozlowski PB, Brudkowska J, Kraszpulski M, Sersen EA, Wrzolek MA, Anzil AP, et al. Microencephalopathy in children congenitally infected with human immunodeficiency virus- a gross-anatomical morphometric study. Acta Neuropathol (Berl) 1997; 93: 136-45.
6. Blanche S, Rouzioux C, Moscato M. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989; 320: 1643-8.
7. Ahmad N. The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus. Crit Rev Clin Lab Sci 2005; 42: 1-34.
8. Douglas G, King B. Maternal-fetal transmission of human immunodeficiency virus: a review of possible routes and cellular mechanisms of infection. Clin Infect Dis 1992; 15: 678-91.
9. Hollander H, Levy J. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med 1987; 106: 692-5.
10. Tardieu M. Mechanisms of the encephalopathy induced by HIV-1. In Fejerman N, Chamoles N, eds. New trends in pediatric neurology. International Congress. Series 1033. Buenos Aires: Excerpta Médica; 1993. p.156-7.
11. Vazeux R, Brousse N, Jarry A, Henin D, Marche C, Vedrenne C, et al. AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 1987; 126: 403-10.
12. Dickson D. Macrophages in HIV CNS disease: microglia as reservoirs and perpetrators of HIV CNS disease. In Gendelman HE, Lipton SA, Epstein L, Swindells S, eds. The neurology of AIDS. New York: Chapman & Hall-Thompson Science; 1998. p. 97-116.
13. Levy J. Human immunodeficiency viruses and the pathogenesis of AIDS. JAMA 1989; 261: 2997-3008.
14. Harouse J, Wroblewska Z, Laughlin M, Hickey W, Schonwetter B, González-Scarano F. Human choroid plexus cell can be latently infected with human immunodeficiency virus. Ann Neurol 1989; 25: 406-11.
15. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (Berl) 1990; 80: 92-4.
16. Everall I, Luthert P, Lantos P. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991; 337: 1119-21.
17. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, et al. Neocortical damage during HIV infection. Ann Neurol 1991; 29: 651-7.
18. Zajicek J, Wing M, Scolding N, Compston D. Interaccions between oligodendrocytes and microglia. Brain 1992; 115: 1611-31.
19. Kielian T. Microglia and chemokines in infectious diseases of the nervous system views and reviews. Front Biosci 2004; 9: 732-50.
20. Cunningham E, De Souza E. Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today 1993; 14: 171-6.
21. Farmer P. AIDS as a global emergency. Bull World Health Organ 2003; 81: 699.
22. Boletín sobre sida en Argentina. Buenos Aires: Ministerio de Salud de la Nación Argentina; 2003.
23. Centers for Diseases Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy associated virus infection. MMWR Morb Mortal Wkly Rep 1986; 35: 334-9.
24. Gallo R, Salahuddin S, Popovic M, Shearer G, Kaplan M, Haynes B, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224: 500-2.
25. Oleske J, Minnefor A, Cooper R, Thomas K, De la Cruz A, Ahdieh H, et al. Immune deficiency syndrome in children. JAMA 1983; 249: 2345-9.
26. Epstein L, Sharer L, Oleske J, Connor E, Goudsmit J, Bagdon L, et al. Neurologic manifestations of immunodeficiency virus infection in children. Pediatrics 1986; 78: 678-87.
27. Belman A, Lantos G, Horoupian D, Novick B, Ultmann M, Dickson D, et al. AIDS: calcification of the basal ganglia in infants and children. Neurology 1986; 36: 1192-9.
28. Grillo E, Arroyo H, Ruggieri V, Czornyj L, Fejerman N, Manterolla A. Complicaciones neurológicas en niños con infección por HIV: evaluación retrospectiva de 6 casos. In SANI, eds: Actas del XI Congreso de la Sociedad Argentina de Neurología Infantil (SANI). Buenos Aires; 1990.
29. Mintz M, Epstein L. Neurologic manifestations of pediatric acquired immunodeficiency syndrome: clinical features and therapeutic approaches. Semin Neurol 1992; 12: 51-6.
30. Brouwers P, Belman A, Epstein L. Central nervous system involvement: manifestations and evaluation. In Pizzo PA, Wilfert C, eds. Pediatric AIDS: the challenge of HIV infection in infants, children and adolescents. Baltimore:Williams & Wilkins; 1991. p. 318-35.
31. Sharer LR. Central nervous system pathology in children with HIV-1 infection. In: Fejerman N, Chamoles N, eds. New trends in pediatric neurology. International Congress. Series 1033. Buenos Aires: Excerpta Médica; 1993. p. 169-74.
32. Vandersteenhoven JJ, Dbaibo G, Boyko OB, Hulette CM, Anthony DC, Kenny JF, et al. Progressive multifocal leucoencephalopathy in pediatric acquired immunodeficiency syndrome. Pediatr Infect Dis J 1992; 11: 232-7.
33. Kauffman WM, Sivit CJ, Fitz Ch, Rakusan TA, Herzog K, Chandra RS. CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical-imaging correlation. AJNR Am J Neuroradiol 1992; 13: 949-57.
34. Fitz C. Inflamatory disease of brain in childhood. AJNR Am J Neuroradiol 1992;13: 551-67.
35. Chamberlain MC, Nichols SL, Chase CH. Pediatric AIDS. A comparition of MR and CT brain imaging. Pediatr Neurol 1991; 7: 357-62.
36. Chamberlain M. Pediatric AIDS: a longitudinal comparative MRI and CT brain imaging study. J Child Neurol 1993; 8: 175-81.
37. Czornyj L, Roccatagliata G, Rodriguez S, Redondo J, Carniglia L, Procack-Psarós C, et al. Estudio tomográfico cerebral en 85 niños HIV+: correlación entre los signos clínicos y los hallazgos por imágenes. Medicina Infantil 1994; 5: 267-73.
38. Epstein LG, DiCarlo FJ Jr, Joshi VV, Connor EM, Oleske JM, Kay D, et al. Primary lymphoma of the central nervous system in children with adquired immnodeficiency syndrome. Pediatrics 1988; 2: 355-63.
39. Czornyj L. Virus de la inmunodeficiencia humana y compromiso del sistema nervioso en la infancia. In Ruggieri V, Caraballo R, Arroyo H, eds. Temas de neuropediatría. Homenaje al Dr. Fejerman. Buenos Aires: Panamericana; 2005. p. 211-32.
40. Kure K, Park Y, Kim T. Immunohistochemical localization of an HIV epitope in cerebral aneurysmal arteriopathy in pediatric acquired immunodeficiency syndrome (AIDS). Pediatr Pathol 1989; 9: 65-7.
41. Moriarty D, Haller J, Loh J, Fikrig S. Cerebral infarction in pediatric acquired immunodeficiency syndrome. Pediatr Radiol 1994; 24: 611-2.
42. Czornyj L, Navoni M, Grañana N, Fejerman N. Cerebrovascular complications in children with vertically transmitted AIDS. Institute of Child Health (Curses & Conferences) Simposium of Cerebrovascular Disease and Stroke in Childhood. UCL. London; 1998.
43. Blanche S, Tardieu M, Duliege A, Rouzioux C, Le Deist F, Fukunaga K, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child 1990; 144: 1210-5.
44. DeCarli C, Civitello LA, Brouwers P, Pizzo PA. The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann Neurol 1993; 34: 198-205.
45. Lobato MN, Caldwell MB, Ng P, Oxtoby MJ. Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium. J Pediatr 1995; 126: 710-5.
46. Cooper ER, Hanson C, Diaz C, Mendez H, Abboud R, Nugent R, et al. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group. J Pediatr 1998; 132: 808-12.
47. Raskino C, Pearson DA, Baker CJ, Lifschitz MH, O'Donnell K, Mintz M, et al. Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team. Pediatrics 1999; 104: e32.
48. Tardieu M, Le Chenadec J, Persoz A, Meyer L, Blanche S, Mayaux MJ. HIV-1-related encephalopathy in infants compared with children and adults. French Pediatric HIV Infection Study and the SEROCO Group. Neurology 2000; 14; 54: 1089-95.
49. Czornyj A, Redondo JJ, Roccatagliata G, Rodríguez SM, Carniglia L, Torolla JL, et al. Head growth rhythm (HGR) in children with neuro-AIDS, before and after AZT treatment. Pediatr Neurol 1994; 11: 94.
50. 12 nutritional deficiency. Pedriatr Neurol 1992; 8: 407.
51. Sperling R, Stratton P, O'Sullivan M, Boyer P, Lambert J, Hammill H, et al. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med 1992; 326: 857-61.
52. Steinbrook R. Preventing HIV infection in children. N Engl J Med 2002; 346: 1842-3.
53. Wade N, Zielinski M, Butsashvili M, McNutt LA, Warren B, Glaros R, et al. Decline in perinatal HIV transmission in New York state (1997-2000). J Acquir Immune Defic Syndr 2004; 36: 1075-82.
54. Connor E, Sperling R, Gelber R, Kiselev P, Scott G, O'Sullivan M, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-80.
55. Taha T, Kumwenda N, Hoover D, Fiscus S, Kafulafula G, Nkhoma C, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA 2004; 292: 202-9.
56. Lallemant M, Jourdain G, Le Coeur S, Mary J, Ngo-Giang-Huong N, Koetsawang S, et al. Perinatal HIV Prevention Trial (Thailand) Investigators. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351: 217-28.
57. Chama C, Audu B, Kyari O. Prevention of mother-to-child transmission of HIV at Maiduguri, Nigeria. J Obstet Gynaecol 2004; 24: 266-9.